HUTCHMED (HCM) stock on watch as company withdraws marketing application for anti-cancer drug in China marketed with Takeda
https://seekingalpha.com/news/4145435-hutchmed-pulls-china-submission-takeda-partnered-drug
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.